News in the Life Sciences Industry

LONDON, Sept. 18, 2019 /PRNewswire/ -- Dante Labs announced today the 10,000 Oral Microbiome Project, aimed at improving the oral care of individuals by leveraging the latest DNA sequencing technologies. The project will improve the understanding of the relationship between diseases and the DNA... Read more ››

? Takeda UK Ltd. is pleased to announce that NICE has recommended the use of Takhzyro® (lanadelumab) subcutaneous injection as an option for preventing recurrent attacks of hereditary angioedema (HAE) in people aged 12 and older, within their final appraisal document (FAD) published today[i]

MELBOURNE, Australia, Sept. 17, 2019 /PRNewswire/ -- Antisense Therapeutics ("ANP" or the "Company") is pleased to advise that a review of the preliminary data from the 6 patients who have completed their 24 weeks of dosing in the Phase II clinical trial of ANP's immunomodulatory therapy, ATL1102... Read more ››

BARCELONA, Spain, Sept. 17, 2019 /PRNewswire/ -- Novo Nordisk today announced findings from an exploratory analysis of the PIONEER trial programme, showing oral semaglutide (3, 7 and 14 mg) improved glycaemic control in people with type 2 diabetes across baseline HbA(1c) levels. Greater reductions... Read more ››

OXFORD, England, Sept. 17, 2019 /PRNewswire/ -- Owen Mumford, a global leader in designing and manufacturing innovative medical devices, has announced it is launching Ateria(®) SafeControl(®) the next generation of safety pen needles. The new and innovative device will be previewed at the 55(th)... Read more ››

HERTFORDSHIRE, England and PITTSBURGH, Sept. 17, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Fulvestrant... Read more ››

Coinciding with World Patient Safety Day, the latest version provides patients and healthcare professionals with a secure mobile-web solution to report adverse events globally

LONDON, Sept. 17, 2019 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1/stable Moody's and BB+/positive S&P) the multinational pharmaceutical company, has launched a new prefilled syringe capability in the US through its affiliate,... Read more ››

LONDON and PHILADELPHIA, Sept. 16, 2019 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood onset neurogenetic disorders with limited or no treatment options, today announced that Joe Horrigan, MD, AMO Pharma's chief medical... Read more ››

STAINES-UPON-THAMES, United Kingdom, Sept. 13, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company,... Read more ››